Treatment for Recurrent Uterine Cancer Advances to Next Research Phase Dr. Kamal Kant Kohli2 Aug 2024 8:00 PM ISTThe latest trial of a new antibody drug that delivers potent chemotherapy directly to cancer cells for patients with advanced or recurrent endometrial...
Gilead Sciences Trodelvy gets European Commission nod for pre-treated HR+/HER2- metastatic breast cancer Ruchika Sharma28 July 2023 4:30 PM ISTFoster City: Gilead Sciences, Inc. has announced that the European Commission (EC) approved Trodelvy (sacituzumab govitecan) as a monotherapy for...
Gilead Sciences gets CHMP positive opinion for Trodelvy in pre-treated HR+/HER2- metastatic breast cancer Ruchika Sharma24 Jun 2023 4:30 PM ISTFoster City: Gilead Sciences, Inc. has announced that the Committee for Medicinal Products for Human Use (CHMP) of the European Medicines Agency...
Gilead Sciences drug Trodelvy modestly delays breast cancer progression in late-stage trial Ruchika Sharma6 Jun 2022 4:09 PM ISTWall Street analysts, on average, expect annual sales of the drug will top $2 billion 2026, according to Refinitiv.
Doctor launches campaign for crowdfunding Rs 1 crore for mother's cancer treatment Medical Dialogues Bureau5 Jan 2022 9:45 AM ISTThe SN Medical College junior resident, Dr Anjali Gupta, has also requested Prime Minister Narendra Modi and Chief Minister Yogi Adityanath for help.
